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Abstract
Objective Post-reperfusion syndrome (PRS), severe
hypotension after graft reperfusion during liver transplan-
tation, is an adverse clinical event associated with poorer
patient outcomes. The purpose of this study was to deter-
mine whether alterations in autonomic control in liver
transplant recipients prior to graft reperfusion are associ-
ated with the subsequent development of PRS.
Methods Heart rate variability (HRV), systolic arterial
blood pressure (SBP) variability, and baroreflex sensitivity
of 218 liver transplant recipients were evaluated using
5 min of ECG and arterial blood pressure signals 10 min
before graft reperfusion along with other clinical parame-
ters. Logistic regression analyses were performed to assess
predictors of PRS occurrence.
Results Seventy-seven patients (35 %) developed PRS
while 141 did not. There were significant differences in
SBP (110 ± 16 vs. 119 ± 16 mmHg, P \ 0.001) and the
ratio of low frequency power to high frequency power (LF/
HF) of HRV (1.0 ± 1.4 vs. 2.1 ± 3.7, P = 0.003) between
the PRS group and No-PRS group. In multivariate logistic
regression analysis, predictors were LF/HF (odds ratio
0.817, P = 0.028) and SBP (odds ratio 0.966, P \ 0.001).
Interpretation Low LF/HF and SBP measured before
hepatic graft reperfusion were significantly correlated with
subsequent PRS occurrence, suggesting that sympathova-
gal imbalance and depressed SBP may be key factors
predisposing to reperfusion-related severe hypotension in
liver transplant recipients.
Keywords Post-reperfusion syndrome 
Liver transplantation  LF/HF  Heart rate variability
Introduction
Post-reperfusion syndrome (PRS) is defined as severe
hypotension occurring within the first 5 min after graft
reperfusion during liver transplantation surgery [1]. PRS is
considered one of the most critical events that can occur
during liver transplantation, because it may be associated
with longer postoperative mechanical ventilation assistance
and intensive care unit stay, as well as higher risk of
postoperative acute renal failure and 1-year mortality
[2–4]. However, the physiological mechanisms underlying
PRS are not fully understood.
Hemodynamic regulation is influenced by cardiovascu-
lar autonomic mechanisms, which are mediated by afferent
neural branches (i.e., the baroreceptor reflex) and efferent
neural branches (i.e., parasympathetic and sympathetic
pathways) [5]. Cardiovascular autonomic impairment has
been reported to be linked with hypotension during gen-
eral anesthesia [6–8]. In addition, chronic liver disease is
associated with cardiovascular autonomic dysfunction,
which is characterized by the impairment of sympathetic
and parasympathetic reactivity [9–12]. These observations
suggest that there is a relationship between cardiovascular
autonomic control and hemodynamic stability during liver
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transplantation surgery. Furthermore, cardiovascular auto-
nomic indices derived from power spectral analysis, such
as the ratio of low frequency power to high frequency
power (LF/HF) or the total power of heart rate variability
(HRV), have attracted attention with regard to their
potential use in predicting hypotensive episodes in patients
undergoing anesthesia or hemodialysis [13–15]. However,
the association between cardiovascular autonomic indices
and reperfusion-related hemodynamic instability during
liver transplantation remains to be established.
We hypothesize that cardiovascular autonomic function
plays a significant role in maintaining arterial blood pres-
sure (ABP) during liver transplantation surgery. The pur-
pose of this study was to evaluate whether alterations in
cardiovascular autonomic function such as a reduction in
LF/HF in liver transplant patients can predict reperfusion-
related hypotension.
Methods
Subjects
Two hundred eighty-one patients, who had undergone liver
transplantation surgery at the Asan Medical Center between
August 2009 and May 2010, were involved in this retro-
spective study. Sixty-three patients were excluded from the
data analysis due to insufficient hemodynamic data for
analysis (n = 39), cardiac arrhythmia during the data col-
lection period (n = 15), or for being underage (\15 years)
patients (n = 9). Of the remaining 218 patients, 88 had
hepatitis virus-related liver cirrhosis, 78 combined hepato-
cellular carcinoma and liver cirrhosis, 21 alcoholic liver
cirrhosis, 13 fulminant hepatic failure, 5 primary biliary
cirrhosis, 4 retransplantation, 3 cryptogenic liver cirrhosis,
2 Wilson disease, 2 primary sclerosing cholangitis, 1
polycystic liver disease, and 1 autoimmune hepatitis. The
study protocol was approved by the Institutional Review
Board of the Asan Medical Center, Seoul, South Korea.
Anesthetic technique
General anesthesia for liver transplantation surgery was
performed according to the Asan Medical Center institu-
tional standard protocol. In brief, anesthesia was induced
with intravenous thiopental sodium, fentanyl and vecuro-
nium. After endotracheal intubation, anesthesia was
maintained with 1 % isoflurane, a 50 % O2/air mixture, and
continuous infusion with fentanyl and vecuronium. ECG,
end tidal CO2 measurement, and pulse oximetry were
monitored during general anesthesia. A twenty-gauge
radial arterial catheter was used for monitoring ABP. A
pulmonary artery catheter (Swan-Ganz CCOmbo V CCO/
SvO2/CEDV, Edwards Lifesciences Corp., CA, USA) was
inserted and connected to a Vigilance system (Vigilance II,
Edwards Lifesciences Corp., CA, USA) for monitoring
hemodynamic variables such as central venous pressure
(CVP), cardiac output (CO), and systemic vascular resis-
tance (SVR). Mechanical ventilation was performed with
tidal volume of 8–10 mL/kg and respiratory rate of
10 breaths/min to maintain normocapnia.
During inferior vena cava clamping before graft reper-
fusion, the piggyback technique was used to maintain
hemodynamic stability. However, veno-venous bypass was
used to minimize hemodynamic instability in cases where
CO was reduced by more than 50 % during inferior vena
cava clamping. With this bypass system, blood flowed from
the femoral and portal veins to the heart via the internal
jugular or subclavian vein.
Definition of PRS
Post-reperfusion syndrome was defined as a decrease in
mean ABP greater than 30 % of the baseline value, for
more than 1 min during the first 5 min after reperfusion of
the liver graft during liver transplantation [1]. Recipients
were categorized into two groups: PRS group (occurrence
of PRS) and No-PRS group (no occurrence of PRS).
Data collection
Hemodynamic variables were routinely recorded during
liver transplantation surgery with a computerized data
acquisition system (DI-720U, DATAQ Instruments, Inc.,
Akron, OH) in all recipients at our institution. Beat-to-beat
ECG and ABP data were digitized at a sampling rate of
500 Hz. Ten minutes before reperfusion of the transplanted
liver graft, 5 min of stable ECG and radial ABP data were
collected using this database system for the retrospective
study. In addition, other hemodynamic variables (CVP,
CO, and SVR) and laboratory variables (serum hemoglo-
bin, serum platelet, serum sodium, and serum potassium)
were collected for off-line analysis.
Data management
Offline data analyses were performed using signal pro-
cessing software (CODAS, DATAQ; DADiSP/Adv DSP,
DSP Development, Cambridge, MA, USA) and custom-
written MATLAB (The MathWorks, Inc., Natick, MA,
USA) program.
Beat-to-beat ECG R wave and systolic ABP (SBP) were
manually inspected to confirm data quality. HRV was
assessed using time and frequency domain indices in addi-
tion to nonlinear analyses. RR interval standard deviation
(SDNN) and the root mean square of successive differences
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in RR intervals (RMSSD) were calculated as representative
time domain measures. SDNN and RMSSD are thought to
correlate with total power and HF, respectively, of the fre-
quency domain of HRV analysis [16].
Nonlinear HRV was analyzed using the Poincare plot
analysis and sample entropy analysis. The Poincare plot
analysis is a nonlinear method of analyzing HRV which
involves analysis of a scatter plot of current versus pre-
ceding RR intervals [17]. SD1 and SD2 represent the
standard deviations of points about the two axes of an
ellipse fitted to the Poincare plot. SD1 is a measure of the
shorter term RR interval variability and SD2 is a measure
of the longer term variability. SD1 has been shown to
correlate with HF of HRV and SD2 with both LF and HF of
HRV [17, 18]. Sample entropy represents another nonlinear
means of analyzing HRV, and is utilized to evaluate the
degree of irregularity or unpredictability in the RR interval
signal [19]. A higher value of sample entropy means
greater unpredictability and irregularity, whereas a lower
value means greater predictability and regularity.
For frequency domain analysis of variability, 300 s time
series data of beat-to-beat RR intervals and SBP were
interpolated to 5 Hz to provide equidistant samples. Power
spectral density was calculated by Welch’s averaging peri-
odograms method with 50 % data overlap, detrending, and
application of a Hanning window. The areas under the power
spectra in the low frequency (0.04–0.15 Hz) and high fre-
quency (0.15–0.40 Hz) regions of HRV and SBP variability
(SBPV) were integrated. Total power was defined as the area
under the power spectrum in the frequencies B0.40 Hz. The
HF of HRV was used as an index of cardiac parasympathetic
activity, and the LF of SBPV was used as an index of sym-
pathetic vasomotor control [20, 21]. The LF/HF of HRV was
used as an index of sympathovagal balance [16].
Cardiac baroreflex sensitivity (BRS) was estimated by
frequency domain transfer function analysis and time
domain sequence analysis. Details of the transfer function
analysis are provided in the previous study [22]. Briefly,
the transfer function magnitude between SBP and RR
interval was estimated using the cross-spectral method. We
calculated the transfer function magnitude between HRV
and SBPV separately as an index of BRS in the low fre-
quency (BRSLF) and high frequency (BRSHF) regions when
coherence was more than 0.5 [23]. Details of the sequence
analysis are also provided in the previous study [24].
Briefly, the slope of the linear relationship between SBP
and RR interval was determined whenever a baroreflex
sequence (3 or more consecutive heartbeats increases in
RR interval with a simultaneous increase in SBP or 3 or
more consecutive heartbeats decreases in RR interval with
a simultaneous decrease in SBP) was identified. The slope
was calculated for sequences with correlation [0.85. The
average of each slope was taken as a measure of baroreflex
sensitivity (BRSSEQ).
Statistics
The hemodynamic variables such as SBP, heart rate (HR),
CVP, CO, and SVR were estimated as 5-min averaged values
10 min before the graft reperfusion during the liver trans-
plantation surgery. All data are expressed as mean ± SD or
number of recipients (percentage). The Chi-square test,
Table 1 Clinical characteristics and laboratory variables in liver transplant recipients
Variable All (N = 218) No-PRS group (n = 141) PRS group (n = 77) P value
Age, years 50.1 ± 8.9 49.4 ± 8.6 51.4 ± 9.2 0.106
Sex, M/F 162/56 (74 %)/(26 %) 107/34 (76 %)/(24 %) 55/22 (71 %)/(29 %) 0.471
BMI, kg/m2 23.9 ± 3.2 24.0 ± 3.3 23.8 ± 3.0 0.731
DM 48 (22 %) 26 (18 %) 22 (29 %) 0.084
Hypertension 28 (13 %) 14 (10 %) 14 (18 %) 0.082
Child score 8.9 ± 2.6 8.7 ± 2.5 9.2 ± 2.8 0.269
MELD score 17.5 ± 9.9 17.4 ± 9.9 17.9 ± 9.9 0.708
Donor type, cadaver/living 20/198 (9 %)/(91 %) 11/130 (8 %)/(92 %) 9/68 (12 %)/(88 %) 0.342
Veno-venous bypass 38 (17 %) 28 (20 %) 10 (13 %) 0.201
Anesthesia duration, min 891 ± 139 892 ± 137 890 ± 144 0.928
Hemoglobin, g/dL 10.0 ± 1.4 10.1 ± 1.5 9.9 ± 1.2 0.438
Platelet, 109/L 37.2 ± 36.9 37.5 ± 38.7 36.6 ± 33.6 0.873
Sodium, mmol/L 138.2 ± 4.3 138.0 ± 4.3 138.6 ± 4.3 0.342
Potassium, mmol/L 3.8 ± 0.6 3.8 ± 0.6 3.8 ± 0.5 0.921
Data are expressed as mean ± SD or number of recipients (percentage) as appropriate. P values were measured by comparing values between
recipients who developed the syndrome (PRS group) and who did not (No-PRS group)
PRS post-reperfusion syndrome, BMI body mass index, DM diabetes mellitus, MELD model for end-stage liver disease
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Student’s t test, or the Mann–Whitney rank sum test, as
appropriate, was used for inter-group comparisons.
The relevant factors associated with PRS occurrence
were included in the univariate logistic regression analy-
sis. Variables with P values\0.1 in the univariate analysis
were included in a multivariate logistic regression analysis
to evaluate independent factors predicting the occurrence
of PRS. Statistical significance was defined as P \ 0.05.
All statistical analyses were performed using statistical
software (SPSS Inc., Chicago, IL, USA).
Results
In a total of 218 liver transplant recipients, 77 recipients
(35 %) developed PRS. Characteristics and laboratory test
results of the liver transplant recipients are provided in
Table 1. There were no significant differences in patient
characteristics and laboratory test results between the PRS
group and the No-PRS group.
Table 2 shows hemodynamic variables and cardiovas-
cular autonomic indices 10 min before reperfusion of new
liver graft during the liver transplantation. There were sig-
nificant differences in SBP and LF/HF of HRV measured
before graft reperfusion, but not in any other components of
HRV, BRS, and SBPV between the two groups (Fig. 1).
In univariate logistic regression analyses, SBP and LF/
HF of HRV were the only significant determinants of PRS
occurrence during the liver transplantation surgery (Table 3).
In multivariate logistic regression analysis, including SVR
and histories of diabetes mellitus and hypertension (P \ 0.1),
the independent predictors of the occurrence of PRS were
Table 2 Hemodynamic variables and cardiovascular autonomic indices before reperfusion
Variable All (N = 218) No-PRS group (n = 141) PRS group (n = 77) P value
SBP, mmHg 116 ± 17 119 ± 16 110 ± 16 \0.001
HR, beats/min 84 ± 16 83 ± 15 85 ± 17 0.482
CVP, mmHg 5.7 ± 2.5 5.5 ± 2.5 5.9 ± 2.5 0.268
CO, L/min 6.6 ± 1.8 6.6 ± 1.6 6.7 ± 2.0 0.662
SVR, dyne s/cm5 965 ± 311 987 ± 312 925 ± 309 0.160
Heart rate variability
Time domain analysis
SDNN, ms 7.7 ± 5.3 7.7 ± 5.3 7.6 ± 5.3 0.914
RMSSD, ms 4.3 ± 3.2 4.1 ± 2.2 4.6 ± 4.4 0.244
Frequency domain analysis
TP, ms2 48.0 ± 101.5 51.3 ± 109.2 41.8 ± 86.1 0.510
LF, ms2 8.2 ± 28.3 9.9 ± 33.8 5.0 ± 12.9 0.219
HF, ms2 6.0 ± 13.1 5.9 ± 12.8 6.3 ± 13.8 0.807
LF/HF 1.7 ± 3.1 2.1 ± 3.7 1.0 ± 1.4 0.003
Nonlinear analysis
SD1, ms 3.0 ± 2.2 2.9 ± 1.6 3.3 ± 3.1 0.245
SD2, ms 10.2 ± 7.4 10.4 ± 7.5 10.0 ± 7.2 0.696
Sample entropy 1.4 ± 0.4 1.4 ± 0.4 1.3 ± 0.5 0.272
Systolic arterial blood pressure variability
TP, mmHg2 10.2 ± 11.1 10.6 ± 12.1 9.6 ± 8.9 0.511
LF, mmHg2 0.9 ± 1.5 1.0 ± 1.4 0.8 ± 1.5 0.400
HF, mmHg2 5.5 ± 7.1 5.5 ± 7.8 5.3 ± 5.4 0.804
Baroreflex sensitivity
BRSLF, ms/mmHg 2.2 ± 2.7 2.2 ± 2.3 2.2 ± 3.3 0.918
BRSHF, ms/mmHg 2.1 ± 2.6 2.0 ± 1.9 2.3 ± 3.5 0.430
BRSSEQ, ms/mmHg 1.6 ± 1.7 1.7 ± 1.7 1.6 ± 1.8 0.705
Data are expressed as mean ± SD or number of recipients (percentage) as appropriate. P values were measured by comparing values between
recipients who developed the syndrome (PRS group) and who did not (No-PRS group)
PRS post-reperfusion syndrome, SBP systolic arterial blood pressure, HR heart rate, CVP central venous pressure, CO cardiac output, SVR
systemic vascular resistance, SDNN standard deviation of all RR intervals, RMSSD root mean square of the successive difference in RR intervals,
TP total power, LF low frequency power, HF high frequency power, LF/HF ratio of low frequency power to high frequency power, SD1 and SD2
standard deviations obtained from Poincare analysis of RR interval variability (see text); BRSLF baroreflex sensitivity in the low frequency
region, BRSHF baroreflex sensitivity in the high frequency region, BRSSEQ baroreflex sensitivity measured by sequence method
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also LF/HF of HRV (odds ratio, 95 % confidence inter-
val 0.817, 0.682–0.979; P = 0.028) and SBP (odds ratio,
95 % confidence interval 0.966, 0.947–0.984; P \ 0.001)
(Table 3).
Discussion
The autonomic nervous system plays an important role in
maintaining the ABP within a normal range. A defect in
autonomic nervous system regulation may contribute to
ineffective blood pressure control. A significant finding of
this study is that in patients undergoing liver transplanta-
tion, patients who subsequently developed PRS, compared
to those who did not, had a significantly depressed LF/HF of
HRV measured prior to graft perfusion. The LF/HF is a
measure of sympathovagal balance. The LF peak in the HR
power spectrum is jointly mediated by the sympathetic and
parasympathetic nervous systems whereas the HF peak is
solely mediated by the parasympathetic nervous system [5].
Thus, a depressed LF/HF is indicative of a relative decrease
in sympathetic tone relative to parasympathetic tone. This
observation implies that those liver transplant patients who
have a relative depression in sympathetic tone relative to
parasympathetic tone are at greater risk of developing PRS.
Liver transplantation surgery is considered the final
option for patients with end-stage liver disease. However,
liver transplantation involves substantial risk. Specifically,
the extended clamping and unclamping of the inferior vena
cava and the portal vein during the surgery pose a risk to the
Fig. 1 Comparisons of a the ratio of low frequency power to high
frequency power (LF/HF) of heart rate variability (HRV), b systolic
arterial blood pressure (SBP), c total power of HRV, and d low
frequency power (LF) of SBP variability (SBPV) between patients
who subsequently developed the post-reperfusion syndrome (PRS
group) and those who did not (No-PRS group) during liver
transplantation. Note that there are significant decreases in LF/HF
of HRV and SBP in the PRS group compared with the No-PRS group.
Straight lines indicate mean value. *P \ 0.05
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patients. In particular, reperfusion of the transplanted liver
graft through the portal vein may induce severe cardiovas-
cular collapse, and this severe hemodynamic change may
adversely affect perioperative morbidity and mortality [2–4].
Many attempts have been made to determine the causes
of PRS during liver transplantation to be able to develop
strategies to minimize the risk of developing PRS [25, 26].
However, the underlying mechanisms of PRS occurrence
remain unclear. We hypothesized that the occurrence of
PRS would be associated with altered cardiovascular
autonomic regulation. To our knowledge, this is the first
study to evaluate underlying mechanisms of reperfusion-
related hypotension during liver transplantation with regard
to alterations in cardiovascular autonomic control.
Table 3 Logistic regression analysis of factors predicting post-reperfusion syndrome
Variable Univariate analysis Multivariate analysis
Coefficient (SE) P value Odds ratio (95 % CI) P value
Age 0.027 (0.017) 0.107
Sex (female vs. male) -0.230 (0.320) 0.472
DM (yes vs. no) 0.571 (0.333) 0.087 1.557 (0.761–3.184) 0.226
Hypertension (yes vs. no) 0.701 (0.408) 0.086 1.551 (0.640–3.762) 0.331
Child score 0.060 (0.054) 0.268
MELD score 0.005 (0.014) 0.707
Donor type (cadaver vs. living) 0.447 (0.474) 0.345
Veno-venous bypass (yes vs. no) -0.507 (0.399) 0.204
Anesthesia duration 0.001 (0.001) 0.927
Hemoglobin -0.086 (0.110) 0.437
Sodium 0.034 (0.036) 0.341
Potassium 0.025 (0.253) 0.920
SBP -0.036 (0.010) \0.001 0.966 (0.947–0.984) \0.001
HR 0.007 (0.009) 0.458
CVP 0.044 (0.057) 0.448
CO -0.164 (0.143) 0.249
SVR -0.001 (0.001) 0.099 1.000 (0.999–1.001) 0.579
Heart rate variability
SDNN -0.003 (0.027) 0.913
RMSSD 0.050 (0.044) 0.259
TP -0.001 (0.002) 0.512
LF -0.010 (0.009) 0.264
HF 0.003 (0.011) 0.806
LF/HF -0.209 (0.093) 0.024 0.817 (0.682–0.979) 0.028
SD1 0.071 (0.063) 0.259
SD2 -0.008 (0.020) 0.694
Sample entropy -0.351 (0.319) 0.271
Systolic arterial blood pressure availability
TP -0.009 (0.014) 0.510
LF -0.093 (0.112) 0.405
HF -0.005 (0.021) 0.803
Baroreflex sensitivity
BRSLF -0.006 (0.054) 0.917
BRSHF 0.042 (0.055) 0.443
BRSSEQ -0.032 (0.085) 0.704
SE standard error, CI confidence interval, DM diabetes mellitus, MELD model for end-stage liver disease, SBP systolic arterial blood pressure,
HR heart rate, CVP central venous pressure, CO cardiac output, SVR systemic vascular resistance, SDNN standard deviation of all RR intervals,
RMSSD root mean square of the successive difference in RR intervals, TP total power, LF low frequency power, HF high frequency power, LF/
HF ratio of low frequency power to high frequency power, SD1 and SD2 standard deviations obtained from Poincare analysis of RR interval
variability (see text), BRSLF baroreflex sensitivity in the low frequency region, BRSHF baroreflex sensitivity in the high frequency region, BRSSEQ
baroreflex sensitivity measured by sequence method
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Hemodynamic homeostasis involves an interaction
between the disturbances to cardiovascular function and
the responses of the cardiovascular control systems to these
disturbances. The autonomic nervous system is the most
important efferent limb of the cardiovascular control sys-
tem [27]. Thus, cardiovascular autonomic regulation is
thought to play a role in maintaining hemodynamic sta-
bility during the severe stressful events of liver transplan-
tation surgery.
Patients with end-stage liver disease are known to
demonstrate abnormal cardiovascular autonomic function,
especially decreased HRV and BRS, and inappropriate
circulatory response to various stimuli [11, 12, 28, 29].
Moller et al. [11] suggested that head-up tilt can induce
abnormalities in sympathetic control and vascular reactiv-
ity, which lead to hemodynamic instability in patients with
liver cirrhosis. Also, Lunzer et al. [12] reported that car-
diovascular regulation to reflex sympathetic activation is
impaired in patients with liver disease, and that autonomic
dysfunction is associated with the impairment of reflex
vascular homeostatic responses to stimulation.
On the basis of the results in this study and other studies,
we can suggest that autonomic dysfunction contributes
to reperfusion-related hemodynamic instability in liver
transplant recipients with PRS. The impairment in auto-
nomic balance may impact the HR response to hypotension
as well as sympathetic vasoconstriction reflex mechanisms.
The autonomic indices of patients in both the PRS and
No-PRS groups in this study were depressed compared to
normal awake subjects published in the previous studies
[16, 24]. In addition, low LF/HF of HRV measured prior to
graft reperfusion was significantly associated with the
development of hypotension after hepatic reperfusion. The
LF/HF of HRV is a well-established marker of altered
sympathovagal balance under a wide variety of conditions
[16]. Decreased LF/HF of HRV is indicative of a change in
autonomic balance toward decreased sympathetic activity
[30]. Our results suggest that a low value of LF/HF of HRV
may indicate a decreased capacity for activating sympa-
thetically mediated HR and vasoconstriction mechanisms
in response to hypotension, thus predisposing to the
development of PRS following reperfusion. These results
are in agreement with the result of previous studies
showing that hypotension episodes during hemodialysis are
significantly associated with decreased LF/HF [13, 31].
Although altered cardiovascular autonomic control may
not provide the entire explanation for the occurrence of
graft reperfusion-related hypotension during liver trans-
plantation surgery, the evaluation of HRV indices,
including LF/HF appears to be particularly helpful in pre-
dicting PRS occurrence.
In the present study, the total power of HRV was not
significantly different between the two PRS and No-PRS
groups. In previous studies, total HRV power has been
found to be associated with the development of hypoten-
sion during general anesthesia [15, 32]. Hanss et al. [15]
reported that preoperative total power of HRV is associated
with the occurrence of hypotension and bradycardia during
anesthesia, and that HRV may be a suitable tool to identify
preoperatively patients at high risk of hemodynamic
events. However, it should be noted that our study popu-
lation involves only liver transplant recipients receiving
general anesthesia compared to previous studies involving
broader groups of patients undergoing anesthesia [15, 32].
In addition, it has been demonstrated that both chronic liver
disease and anesthetic agents can depress cardiovascular
autonomic function [9, 10, 33, 34]. Therefore, we could
postulate that some of the HRV indices might not be useful
when severely depressed due to concurrent conditions (e.g.,
liver disease and anesthesia).
Interestingly, we found that the LF of SBPV and SVR
were not significantly different between PRS group and
No-PRS group. However, it is not clear whether reperfu-
sion-related severe hypotension may be associated with the
sympathetic dysfunction of peripheral origin or the inhi-
bition of the central regulatory mechanism of the sympa-
thetic nervous system. Therefore, further study would be
required for clarifying the relationships between central
and peripheral sympathetic dysfunction as the underlying
mechanism of reperfusion hypotension in liver transplant
recipients.
We also found that SBP in the PRS group was decreased
compared to that in the No-PRS group, and that low SBP
before graft reperfusion is a significant determinant of PRS
occurrence in liver transplant recipients. This observation
suggests the hypothesis that maintaining a more elevated
intra-operative SBP prior to reperfusion may reduce the
risk of developing PRS.
The role of serum potassium as an underlying mecha-
nism of PRS occurrence has been the subject of consider-
able debate [35, 36]. In the present study, serum potassium
levels measured before graft reperfusion were not signifi-
cantly different between the PRS group and the No-PRS
group. The reason is not clear why in this study the serum
potassium level was not significantly associated with PRS
occurrence. One possible explanation is that serum potas-
sium level was controlled strictly during the anhepatic
phase by the administration of insulin, sodium bicarbonate,
or diuretic according to our institutional standard anesthetic
protocol (serum potassium level 3.8 ± 0.6 mmol/L).
In this study, veno-venous bypass application during
inferior vena cava clamping was not significantly associ-
ated with graft reperfusion-related severe hypotension.
This finding is consistent with a previous study in which
the occurrence of the syndrome of cardiovascular collapse
following graft reperfusion was similar whether veno-venous
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bypass was used or not [37]. Therefore, although veno-
venous bypass application is known to be useful for
maintaining hemodynamic stability during inferior vena
cava clamping, it does not appear to be preventive of PRS.
The present study has several limitations. Cardiovascular
autonomic dysfunction (depression) due to the patient
conditions (severe liver disease and anesthesia) likely
affected the autonomic parameters measured. For example,
it is likely that general anesthesia depresses the LF peak and
the use of mechanical breathing increases the HF peak, thus
depressing the LF/HF. However, since the same conditions
and methods were applied to both patients with and without
PRS, we could conclude that low LF/HF was significantly
correlated with PRS occurrence. Nonetheless, the results of
our study need to be interpreted with caution. Because
overall cardiovascular autonomic indices were too small to
provide sufficient information about baroreflex mechanisms
[38], the role of cardiovascular autonomic control on PRS
occurrence may be unremarkable in helping patient evalu-
ation or diagnosis. Secondly, this study involved retro-
spective analysis of previously collected data. Lastly, the
study focused mainly on whether analysis of cardiovascular
parameters obtained clinically just prior to reperfusion was
predictive of PRS. We did not evaluate hemodynamic
variables and cardiovascular autonomic indices under
resting conditions. Therefore, further study involving rest-
ing data will be needed to fully understand the relationship
of cardiovascular autonomic measures to PRS.
Conclusions
We found that depressed sympathovagal balance and a
lower resting SBP were associated with the occurrence of
post-reperfusion severe hypotension during liver transplan-
tation. This finding also suggests that altered sympath-
ovagal balance with sympathetic withdrawal is associated
with hemodynamic instability after acute stressful events
such as reperfusion in liver transplant recipients. Our
results further emphasize the importance of the beneficial
role of the cardiovascular autonomic control system as a
defense mechanism for maintaining blood pressure stabil-
ity during liver transplantation. We also found that
decreased SBP prior to graft reperfusion was associated
with increased risk of the development of post-reperfusion
hypotension. This finding suggests the hypothesis that
maintaining a higher SBP prior to reperfusion may reduce
the risk of PRS.
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